Most specialty revenue leaks do not start with a dramatic payer audit. They start with a claim that never should have left the billing office.

Missing modifiers on single-dose oncology drugs. IMRT planning codes billed again after the plan was already paid. A diagnostic cystoscopy stacked onto a therapeutic procedure that already includes looking into the bladder. Behavioral health care management billed without documented consent or the required team roles. Prior authorization sitting in a fax folder while the claim goes out “to meet the week.”

Each of those is a clean-claim failure. Medicare and Medicaid define a clean claim in plain operational language: a claim that can be processed without the contractor or State chasing more information from you or a third party. Commercial payers use the same idea even when their contracts use different words.

Here is the main point: independent specialty practices improve cash flow faster by fixing specialty-specific claim construction before submission than by adding more denial appeals after the fact. Clean claims submissions specialty billing is not a generic checklist. It is radiation planning and delivery rules, oncology drug and administration hierarchy, urology bundling and 2026 biopsy codes, and behavioral health care-management documentation, scrubbed against current National Correct Coding Initiative (NCCI) edits before the claim hits the payer.

This post explains what “clean claim” means in CMS and Medicaid terms, where each specialty fails, how to build a real scrubbing workflow, when NCCI and Medically Unlikely Edits (MUEs) matter, what documentation stops rejects, how denial loops form, and a practical checklist you can run tomorrow.

What a clean claim actually is

Medicare language, in everyday words

The Medicare Claims Processing Manual, Chapter 1, section 80.2, defines a clean claim as one that does not require the Medicare contractor to investigate or develop the claim before adjudication. In practice, that means the claim has the data elements, coding, and supporting information the contractor needs to decide payment without calling you, requesting records up front, or sending the claim into an “other claim” development track.

Claims that need outside development are “other” claims. Examples include missing routine data, medical information requests, or discrepancies that force contact with the provider or another source. Those claims sit outside the clean-claim payment clock.

Why the clock matters: Medicare’s payment ceiling and interest rules for clean claims are built around receipt and timely adjudication. When your claim is clean, you are inside the rules that push contractors to pay promptly. When it is not clean, you are in development, and the delay is often on you.

Medicaid language, in everyday words

Federal Medicaid rules at 42 CFR § 447.45 define a clean claim as one that can be processed without obtaining additional information from the provider or a third party. It includes claims with errors that originated in the State’s own claims system. It does not include claims from a provider under fraud or abuse investigation, or claims under medical necessity review.

The same regulation also sets State payment expectations for practitioner clean claims: generally, pay 90% within 30 days of receipt and 99% within 90 days. That is a State agency obligation, not a guarantee that every commercial managed Medicaid plan will move at the same speed. Still, it shows why States and plans care about clean-claim rates: delayed clean claims create compliance and cash-flow pressure on both sides.

What “clean” is not

A clean claim is not the same thing as a medically necessary claim that will never be audited later. Comprehensive Error Rate Testing (CERT) and other medical review can still request records after payment. CMS’s documentation booklet (MLN909160) is clear: if the record cannot support coverage, coding, and the level billed, payment can be denied or recovered.

So think of two layers:

  1. Front-door clean: the claim passes electronic and payer edits and can be adjudicated without development.
  2. Back-door supportable: the chart can survive medical review if CERT, a Recovery Audit Contractor (RAC), or a Medicare Advantage plan asks for records.

Specialty practices that only chase front-door acceptance still lose money later. Practices that only obsess over charts but skip scrubbing still bleed days in accounts receivable (A/R). You need both.

Electronic claim reality for specialty offices

Most professional claims for these specialties go out as 837P (electronic professional claim) or, when an Administrative Simplification Compliance Act (ASCA) exception applies, on the CMS-1500 paper form. CMS’s MLN booklet on Medicare Billing: CMS-1500 & 837P (MLN006976, December 2025) stresses current diagnosis and procedure codes, proper modifiers, correct Place of Service (POS), and filing with the right Medicare Administrative Contractor (MAC) for Fee-for-Service (FFS) patients versus the Medicare Advantage plan for MA members.

A claim sent to the wrong payer or MAC is not a coding problem. It is still a clean-claim failure because it will bounce or stall before anyone looks at your radiation plan or drug units.

Specialty-specific failure modes

Generic practice-management advice says “check eligibility and code correctly.” Specialty RCM needs the actual failure modes.

Radiation oncology: planning, delivery, and weekly management

Radiation claims fail clean when planning components are unbundled, when weekly management is miscoded, or when documentation cannot support the complexity billed.

IMRT planning bundling (especially hospital outpatient). CMS MLN Matters SE18013 reminds Outpatient Prospective Payment System (OPPS) hospitals that Intensity-Modulated Radiation Therapy (IMRT) planning code 77301 already includes a set of planning-related services in the Ambulatory Payment Classification (APC) payment. Do not also report Current Procedural Terminology (CPT) codes such as 77014, 77280, 77285, 77290, 77295, 77306 through 77321, 77331, and 77370 when those services are part of developing the IMRT plan, even if they fall on different dates of service. Put those charges into the 77301 charge. Separate reporting is a classic overpayment and reject pattern.

Freestanding and professional billing has its own Local Coverage Determination (LCD) and article rules. MAC articles for IMRT still expect a physician statement explaining why IMRT is needed instead of conventional or three-dimensional planning, a prescription with dose constraints for targets and organs at risk, signed review of isodose distributions and dose-volume histograms, and dosimetric verification signed by the radiation oncologist and medical physicist. Missing those pieces may not always stop the first electronic edit, but they turn paid claims into medical-review problems and turn prior-authorization packages into denials.

Clinical treatment planning. Complex clinical treatment planning (77263) is a professional service used when planning involves highly complex blocking, custom shielding, tangential ports, special wedges or compensators, three or more treatment areas, rotational or special beam considerations, or combined modalities. Bill it once per course when criteria are met, and make sure the note actually describes that complexity. Upcoding planning level is a favorite auditor target.

Weekly radiation treatment management. CPT 77427 is radiation treatment management for five treatments. CMS NCCI Policy Manual Chapter I is explicit that modifier 59 shall not be used with 77427. Trying to force separate payment with a Distinct Procedural Service modifier is a scrubber red flag, not a clever workaround.

Delivery coding after the 2026 rewrite. Independent clinics still adapting to technique-agnostic delivery levels must match the documented delivery complexity to the code billed. If your system still maps “IMRT equals highest delivery code” without checking the current CPT descriptors and payer rules for that date of service, expect downcodes and rejects. Scrub delivery against the note for that fraction, not against a template from 2024.

Medical oncology: drugs, waste modifiers, and administration hierarchy

Medical oncology clean claims break on three predictable points: drug units and waste reporting, administration hierarchy, and missing or mismatched drug lines.

JW and JZ modifiers. For separately payable Medicare Part B drugs from single-dose containers or single-use packages, CMS requires either:

  • JW on a separate line for discarded units (when waste is billable under the rules), or
  • JZ on the administered line when nothing was discarded.

MLN Matters MM13056 and Medicare Claims Processing Manual Chapter 17 explain the rule. Effective July 1, 2023, JZ is required when there is no discarded amount. Claims that omit JW or JZ on applicable single-dose drugs invite edits and audits. Document discarded amounts in the medical record. Do not bill JW when the administered dose plus waste is less than or equal to one billing unit in a way that would overpay; follow Chapter 17’s unit examples carefully.

One initial administration code per encounter. Noridian (Medicare Administrative Contractor for several jurisdictions, including guidance used widely as a teaching reference) and the NCCI Policy Manual Chapter XI state that CPT codes such as 96360, 96365, 96374, 96409, and 96413 are “initial” service codes. Generally, report only one initial code per patient encounter unless separate IV access sites are medically necessary or a separately identifiable later encounter occurs. A second initial code on the same day without a valid modifier and clinical reason is a clean-claim killer.

Hierarchy and hydration. Chemotherapy services sit above therapeutic infusions, which sit above hydration. Infusions sit above pushes, which sit above injections. Hydration that only keeps a line open, or hydration that is integral to chemotherapy, is not separately billable. Start and stop times matter. If stop time is missing, many payers will only allow a push-level service regardless of how long nursing believes the infusion ran.

Drug line must support the admin code. Facility and Part A teaching from Noridian is blunt: chemotherapy administration often returns or denies when an approved chemotherapy drug is not on the claim. Office billers see the same logic from commercial scrubbers. Bill the HCPCS drug code with correct units, National Drug Code (NDC) where required, and the matching administration code.

Urology: separate procedures, stents, and 2026 prostate biopsy codes

Urology claims look simple until NCCI “separate procedure” logic and new biopsy codes meet the claim.

Diagnostic cystoscopy with therapeutic work. CPT 52000 (cystourethroscopy) is designated a separate procedure. Under CMS NCCI Policy Manual Chapter I, a “separate procedure” is not separately reportable with a related procedure in an anatomically related region, often through the same approach. When the urologist looks and then treats (biopsy, tumor destruction, stent placement such as 52332, and similar therapeutic cystoscopic work) in the same session, bill the therapeutic code. Stacking 52000 beside it usually denies as bundled. A modifier path only exists when the diagnostic look is truly a distinct session or distinct anatomic circumstance and the Correct Coding Modifier Indicator (CCMI) for that code pair allows an NCCI-associated modifier. Many same-session diagnostic-plus-therapeutic cystoscopy pairs do not allow a modifier bypass. Check the current-quarter Procedure-to-Procedure (PTP) file rather than habit.

Prior authorization before the procedure, not after. Image-guided prostate biopsy pathways and many stone and stent procedures commonly need prior authorization from commercial and Medicare Advantage plans, often through a radiology benefit manager. A surgically perfect note will not save a claim that went out without a valid authorization number when the plan required one. Put authorization status in the scrub queue as a hard stop.

2026 prostate biopsy coding. The AMA CPT 2026 code set (effective January 1, 2026) restructured prostate biopsy reporting. Specialty coding sources and the CY 2026 Physician Fee Schedule rulemaking identify deletion of the old catch-all 55700 and introduction of a new family roughly spanning 55707 through 55715, organized by approach and imaging guidance (transrectal vs transperineal, ultrasound vs MRI-fusion vs in-bore CT/MRI, systematic vs targeted). Continuing to bill 55700, or billing imaging guidance on a separate line the old way, produces rejects. Map every operative note to the new family before claim creation, and update charge masters and prior-auth templates to the new codes.

Behavioral health: care management, consent, and team roles

Behavioral health clean claims fail less on CPT syntax and more on missing program elements that payers treat as claim defects.

CMS MLN909432 (Behavioral Health Integration Services, January 2026) explains two Medicare BHI paths:

  1. Psychiatric Collaborative Care Model (CoCM) using codes such as 99492 (first month, 70 minutes of behavioral health care manager time), 99493 (subsequent months, 60 minutes), and add-on 99494 (each additional 30 minutes), plus G2214 for a 30-minute monthly option.
  2. General Behavioral Health Integration (BHI) using 99484 (at least 20 minutes of clinical staff time directed by the billing practitioner) or G0323 when a clinical psychologist or clinical social worker furnishes the time.

Required pieces that scrubbers and auditors look for:

  • An initiating visit (Annual Wellness Visit, Initial Preventive Physical Exam, qualifying Evaluation and Management (E/M), Transitional Care Management, or, for G0323, psychiatric diagnostic evaluation 90791).
  • Patient consent documented in the record (verbal is allowed; document it; cost sharing must be explained).
  • For CoCM: treating practitioner, behavioral health care manager, psychiatric consultant, registry, validated rating scales, and weekly caseload consultation.
  • Time thresholds that match the code, using CPT time rules.

Advanced Primary Care Management (APCM) add-ons in 2026. Starting January 1, 2026, optional non-time-based add-on HCPCS codes G0568, G0569, and G0570 may be reported with APCM base codes G0556, G0557, or G0558 in the same month for CoCM or general BHI furnished with APCM. They are not stand-alone codes. Billing an add-on without the matching APCM base code from the same practitioner in the same month is a built-in reject.

Independent specialty behavioral health clinics that are not the patient’s primary care focal point should stay on the standalone CoCM or BHI codes rather than forcing an APCM pathway they do not meet.

Build a claim scrubbing workflow that matches specialty work

A useful scrub is not “run clearinghouse edits and hit submit.” It is a staged gate that catches specialty failures early.

Stage 1: Registration and coverage truth

  • Confirm active coverage for the date of service.
  • Separate Original Medicare FFS (bill the MAC) from Medicare Advantage (bill the plan).
  • Check Medicare Secondary Payer (MSP) indicators. Billing Medicare as primary when another payer is primary is an automatic delay.
  • Capture referring or ordering provider National Provider Identifier (NPI) when required.

Stage 2: Clinical and authorization gate (before coding)

  • Radiation: signed prescription, plan approval, and (for IMRT) medical-necessity statement and verification documents available.
  • Medical oncology: drug orders, vial size, administered dose, discarded amount, and start/stop times in the Medication Administration Record (MAR).
  • Urology: operative note complete; prior auth status for biopsy, advanced imaging, stents, or lithotripsy as plan rules require.
  • Behavioral health: consent on file; initiating visit dated; registry and rating scales present for CoCM.

No authorization when required means the claim does not leave Stage 2.

Stage 3: Coding construction

  • Use current ICD-10-CM diagnoses to the highest number of characters available (MLN006976).
  • Select the most comprehensive CPT or HCPCS code that describes the service; do not unbundle (NCCI Policy Manual Chapter I).
  • Apply only clinically justified modifiers. Never append 59, XE, XP, XS, or XU solely to bypass an edit.
  • For drugs, attach JW or JZ when the single-dose policy applies.
  • For infusions, pick one initial administration code and correct sequential or concurrent add-ons.

Stage 4: Automated edits with a human specialty review

Run:

  • Clearinghouse HIPAA syntax edits.
  • Payer-specific companion guide edits.
  • Current-quarter NCCI PTP and MUE files (practitioner vs facility table as appropriate).
  • Internal specialty rules (for example: reject 52000 with same-day therapeutic cystoscopy; reject IMRT component codes with 77301 in OPPS; reject second 96413 without modifier logic; reject G0568 without an APCM base code).

A biller who knows radiation or oncology should review flagged specialty claims. A generic edit queue will miss half of these.

Stage 5: Final submit and response handling

  • Submit 837P.
  • Work 999 (acknowledgment) and 277CA (claim acknowledgment) rejects the same day.
  • Post remittance Claim Adjustment Reason Codes (CARCs) and Remittance Advice Remark Codes (RARCs) into a specialty denial taxonomy, not a single “denied” bucket.

NCCI, MUEs, and modifiers without the fog

Procedure-to-Procedure (PTP) edits

NCCI PTP edits are pairs of codes that generally should not be reported together for the same patient by the same provider on the same date. The Column One code may be paid; the Column Two code is denied unless a valid NCCI-associated modifier applies and the Correct Coding Modifier Indicator (CCMI) is 1.

  • CCMI 0: modifier cannot bypass the edit. Fix the coding.
  • CCMI 1: modifier may bypass only when clinical criteria are met and the record supports a separate encounter, separate structure, or other allowed distinction.
  • CCMI 9: indicator not applicable (typically deleted edits).

NCCI-associated modifiers include anatomic modifiers, global surgery modifiers (24, 25, 57, 58, 78, 79), and 27, 59, 91, XE, XS, XP, XU. Modifiers 22, 76, and 77 do not bypass PTP edits.

CMS also created the X{EPSU} modifiers to be more specific than 59. Use the more specific modifier when it fits. Use 59 only when no better modifier explains the situation.

Medically Unlikely Edits (MUEs)

An MUE is the maximum units of service usually reported for a code for the same beneficiary by the same provider on the same date. CMS publishes most values quarterly; some remain confidential. The MUE Adjudication Indicator (MAI) matters:

  • MAI 1: claim-line edit; appropriate line splitting with modifiers may apply in limited cases.
  • MAI 2: absolute date-of-service policy edit; overrides are generally contrary to CMS policy.
  • MAI 3: date-of-service edit based on clinical benchmarks; appeal with strong documentation may succeed in rare cases.

MUEs are coding edits, not a license to bill up to the MUE value every day. Advance Beneficiary Notices (ABNs) do not shift MUE liability to the patient.

Specialty examples that belong in your scrubber

  • Do not use modifier 59 with 77427.
  • Do not report IMRT component planning codes with 77301 under the OPPS bundling rule described in SE18013.
  • Do not report two initial infusion codes (96413 plus 96365, for example) for one encounter without a documented separate IV site or separate encounter that justifies an NCCI-associated modifier.
  • Do not report a separate-procedure diagnostic cystoscopy with same-session related therapeutic endoscopy when the PTP file and separate-procedure policy say no.
  • Do not treat MUE values as productivity goals for drug units or biopsy cores.

Documentation that prevents rejects and later takebacks

CMS MLN909160 frames the documentation rule simply: submit enough documentation to support your claims. Incomplete or illegible records can support denial. Missing signatures, missing orders, and notes that do not show the service was provided at the level billed are classic CERT errors.

Specialty documentation that protects clean claims:

Radiation oncology

  • Diagnosis and stage supporting the treatment site.
  • Signed and dated prescription with dose, fractionation, targets, and constraints.
  • For IMRT: physician rationale versus conventional or 3D planning; DVH and isodose review; physicist and physician verification.
  • Daily treatment record matching fractions billed to weekly management units.
  • Image guidance and motion management described as actions taken, not checkbox labels.

Medical oncology

  • Order for each drug and supportive medication.
  • MAR with drug name, dose, route, start and stop times, and waste.
  • Pathology or clinical indication tying diagnosis codes to anti-neoplastic therapy.
  • Separate E/M notes if billing E/M with modifier 25 on an infusion day; the E/M must be significant and separately identifiable. Drug administration codes already include the work of a brief nursing visit (99211 is not separately reported with those admin codes).

Urology

  • Operative note that states approach, imaging guidance, lesions targeted, and devices placed.
  • Explicit language when a service is a distinct session or distinct site (needed if any modifier strategy is even possible).
  • Pathology requisitions that match biopsy coding.
  • Authorization reference numbers stored where billers can see them.

Behavioral health / care management

  • Consent and cost-sharing discussion.
  • Initiating visit.
  • Care plan and updates when the patient is not improving.
  • Validated rating scale results.
  • For CoCM: registry evidence and weekly psychiatric consultation notes.
  • Time logs that support 99492 / 99493 / 99484 when those time-based codes are used (APCM add-ons G0568–G0570 are not time-based, but clinical evidence of the service is still required).

Common denial and reject loops (and how to break them)

Loop 1: Reject, correct one field, reject again

Example: claim rejects for missing JZ, biller adds JZ, claim then denies for unit mismatch against the vial size. Break it by fixing drug units, NDC, JW/JZ, and admin code together in one pass.

Loop 2: Paid, then medical review denial

Example: IMRT delivery and planning paid, then additional documentation request fails because the IMRT necessity statement or DVH review is missing. Break it by treating documentation completeness as a pre-bill gate for high-cost radiation and drug claims, not as an appeal task.

Loop 3: Authorization after the fact

Example: prostate MRI-fusion biopsy performed, claim denies for no prior auth, staff seeks retro auth and loses weeks. Break it by scheduling only after auth is active, with the authorization number required in the charge entry screen.

Loop 4: Modifier inflation

Example: every bundled urology or infusion pair gets modifier 59. Payer pays once, then audits and recoups. Break it by allowing NCCI-associated modifiers only when CCMI = 1 and the note documents a true separate encounter or structure. Prefer XE / XS / XP / XU when they fit.

Loop 5: Behavioral health month stacking

Example: practice bills 99492 and 99484 for the same patient in the same month, or bills G0568 without G0557. Break it with month-level edits: one BHI pathway per patient per month, and APCM add-ons only with a same-practitioner APCM base code.

Loop 6: Wrong payer routing

Example: MA patient claim sent to the Part B MAC. Break it with eligibility scrapes that write payer ID and plan type into the claim header before coding starts.

Practical checklist for clean claims submissions in specialty billing

Use this as a daily pre-submit list for independent radiation oncology, medical oncology, urology, and behavioral health teams.

Coverage and claim header

  • Eligibility verified for date of service
  • Correct payer (MAC vs MA vs commercial) and addressable payer ID
  • MSP checked
  • Patient, rendering, billing, and referring NPIs complete
  • POS matches where the service occurred

Authorization and clinical gate

  • Prior auth present when the plan requires it for that CPT/HCPCS
  • Orders and signed reports available for the codes billed
  • Consent on file for BHI / CoCM / APCM care management

Coding integrity

  • ICD-10-CM codes current and as specific as documentation supports
  • CPT/HCPCS match the note (including 2026 prostate biopsy family when applicable)
  • No unbundled IMRT planning components with 77301 (OPPS rule)
  • No diagnostic 52000 with same-session related therapeutic cystoscopy unless PTP and documentation truly allow it
  • One initial infusion/admin code per encounter unless separate access or encounter is documented
  • JW or JZ present on applicable single-dose Part B drug lines
  • Drug units match administered (and discarded) amounts and HCPCS dose descriptors
  • BHI time or APCM pairing rules met; no conflicting care-management stack

NCCI / MUE

  • Current-quarter PTP pairs reviewed for flagged combinations
  • Modifiers used only when clinically justified; no 59 on 77427
  • Units within published MUE expectations or documented for appeal if MAI 3

Before submit / after submit

  • Clearinghouse and specialty scrubber clean
  • 999 / 277CA rejects worked same day
  • Denial codes mapped to a specialty reason code for root-cause fixes

What the practice should do next

  1. Pick your top three reject reasons by specialty from the last 90 days. Do not start with a 40-item policy manual. Start with the codes that actually delay payroll.
  2. Hard-code specialty scrub edits for IMRT bundling, JW/JZ, one initial admin code, cystoscopy bundling, 2026 biopsy code map, and BHI/APCM pairing.
  3. Move prior auth into the scheduling system, not the denial desk.
  4. Train clinicians on the few documentation lines that unlock payment (IMRT rationale, infusion stop times, distinct-session language, BHI consent and rating scales).
  5. Review NCCI and MUE files every quarter on the same calendar as CMS posts updates.
  6. Audit ten claims a month per specialty against the checklist above, including charts, not just remits.

Clean claims submissions are an operations habit. Specialty practices that treat them that way shorten A/R, cut rework, and walk into payer audits with records that already match the claim.

How ALH Billing Solutions helps

ALH Billing Solutions works with independent specialty practices in the Woodland and Vancouver, Washington area and beyond, with a focus on radiation oncology, medical oncology, urology, and behavioral health. On clean claims, that means specialty coding review, prior authorization tracking tied to the procedure, claim scrubbing against current NCCI and payer edits, and denial management that fixes the root cause instead of endlessly resubmitting the same broken claim.

Subscribe to the newsletter

Get practical medical billing insights delivered to your inbox.

Or open the signup form.

Conclusion

A clean claim is a claim a payer can adjudicate without chasing you for missing pieces. In specialty RCM, the missing pieces are rarely “forgot the ZIP code.” They are IMRT components billed twice, drug waste modifiers skipped, a second initial infusion code, a bundled cystoscopy, an obsolete prostate biopsy code, or care management without consent and team evidence.

Define clean the way CMS and Medicaid do. Scrub with specialty rules. Document for both the edit engine and the later auditor. Break denial loops at the source. That is how independent oncology, urology, and behavioral health practices turn clean claims submissions into reliable cash flow.

Sources

  1. CMS, Medicare Claims Processing Manual, Chapter 1 – General Billing Requirements (clean claim discussion at §80.2): https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104C01.pdf
  2. 42 CFR § 447.45 – Timely claims payment (Medicaid clean claim definition and payment timeframes): https://www.law.cornell.edu/cfr/text/42/447.45
  3. CMS, Medicare Billing: CMS-1500 & 837P, MLN006976 (December 2025): https://www.cms.gov/files/document/mln006976-medicare-billing-cms-1500-837p.pdf
  4. CMS, Complying with Medical Record Documentation Requirements, MLN909160 (December 2024): https://www.cms.gov/files/mln909160-complying-with-medical-record-documentation-requirements.pdf
  5. CMS, Medicare NCCI Policy Manual, Chapter I (2026 final): https://www.cms.gov/files/document/01-chapter1-ncci-medicare-policy-manual-2026-final.pdf
  6. CMS, Medicare NCCI Medically Unlikely Edits (MUEs): https://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits/medicare-ncci-medically-unlikely-edits-mues
  7. CMS, MLN Matters SE18013, Intensity-Modulated Radiation Therapy (IMRT) Planning Services Editing: https://www.cms.gov/sites/default/files/2021-03/SE18013.pdf
  8. CMS, MLN Matters MM13056, New JZ Claims Modifier for Certain Medicare Part B Drugs: https://www.cms.gov/files/document/mm13056-new-jz-claims-modifier-certain-medicare-part-b-drugs.pdf
  9. CMS, Medicare Claims Processing Manual, Chapter 17 (discarded drugs; JW/JZ policy context): https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c17.pdf
  10. CMS, Behavioral Health Integration Services, MLN909432 (January 2026): https://www.cms.gov/files/document/mln909432-behavioral-health-integration-services.pdf
  11. Noridian Medicare JF Part B, Chemotherapy and Nonchemotherapy (administration hierarchy; one initial code; bundling): https://med.noridianmedicare.com/web/jfb/topics/drugs-biologicals-injections/chemotherapy-and-nonchemotherapy-bundling-and-unbundling-of-services-and-supplies
  12. CMS Internet-Only Manual Pub. 100-04, Chapter 12, §30.5 (Payment for Codes for Chemotherapy Administration and Nonchemotherapy Injections and Infusions), as referenced in Noridian guidance above.
  13. American Medical Association, AMA releases CPT 2026 code set (Jan. 1, 2026 effective date for new Category I codes): https://www.ama-assn.org/press-center/ama-press-releases/ama-releases-cpt-2026-code-set
  14. Federal Register, CY 2026 Physician Fee Schedule final rule materials discussing prostate biopsy CPT family (55705–55715 range in rulemaking): https://www.federalregister.gov/documents/2025/11/05/2025-19787/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other
  15. Society of Interventional Radiology, Coding Q&A on 2026 prostate biopsy codes (55707–55715; 55700 deleted): https://www.sirweb.org/ir-quarterly/clinical-practice/coding-qa-new-and-revised-codes-for-2026/